Profile of Inhaled Levodopa and its Potential in the Treatment of Parkinson's Disease: Evidence to Date Citation: Patel, A. B.
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact o
![Clinical implications of gastric complications on levodopa treatment in Parkinson's disease - ScienceDirect Clinical implications of gastric complications on levodopa treatment in Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1353802020301103-gr1.jpg)
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease - ScienceDirect
![Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro](https://www.eneuro.org/content/8/4/ENEURO.0559-20.2021/F1.large.jpg)
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro
![The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-021-01747-1/MediaObjects/12325_2021_1747_Figa_HTML.png)
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink
![Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features - Ray Chaudhuri - 2018 - Movement Disorders - Wiley Online Library Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features - Ray Chaudhuri - 2018 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/a1ae0e1f-7708-410c-b102-8c0daa0a4f2d/mds27386-fig-0001-m.jpg)
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features - Ray Chaudhuri - 2018 - Movement Disorders - Wiley Online Library
![Comparison of the risk of motor complications and other adverse events... | Download Scientific Diagram Comparison of the risk of motor complications and other adverse events... | Download Scientific Diagram](https://www.researchgate.net/publication/275861327/figure/fig2/AS:669011947831325@1536516286940/Comparison-of-the-risk-of-motor-complications-and-other-adverse-events-associated-with.png)
Comparison of the risk of motor complications and other adverse events... | Download Scientific Diagram
![Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial - The Lancet Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/7af10392-2b84-4c95-88c5-b5637c50f794/gr1.gif)
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial - The Lancet
![A review of current and novel levodopa formulations for the treatment of Parkinson's disease. | Semantic Scholar A review of current and novel levodopa formulations for the treatment of Parkinson's disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9c8afb5ba98cdc54ef9839bb2a07ecf41e33a089/3-Table1-1.png)
A review of current and novel levodopa formulations for the treatment of Parkinson's disease. | Semantic Scholar
![Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2016/09/Changes_in_motor_response_associated_with.png)
Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY
![Progress Fighting Parkinson's Drug Side Effects; “I'm basically going to be incapacitated by the drug that's helping me, and that's terrifying,” | Bamboo Innovator Progress Fighting Parkinson's Drug Side Effects; “I'm basically going to be incapacitated by the drug that's helping me, and that's terrifying,” | Bamboo Innovator](https://bambooinnovator.files.wordpress.com/2013/03/pj-bn319a_lab_g_20130325175416.jpg)
Progress Fighting Parkinson's Drug Side Effects; “I'm basically going to be incapacitated by the drug that's helping me, and that's terrifying,” | Bamboo Innovator
![Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study - IOS Press Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study - IOS Press](https://content.iospress.com/media/jpd/2020/10-3/jpd-10-3-jpd201978/jpd-10-jpd201978-g001.jpg)
Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study - IOS Press
![Frontiers | Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence Frontiers | Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence](https://www.frontiersin.org/files/Articles/805388/fphar-13-805388-HTML/image_m/fphar-13-805388-g002.jpg)
Frontiers | Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence
![Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/89798a2e-ddba-44f6-b5b4-4d33cfbb7870/rstb20140184f01.jpg)